Prognosis in HIV-infected patients with non-small cell lung cancer

被引：0
|
作者：
K Sigel
K Crothers
R Dubrow
K Krauskopf
J Jao
C Sigel
A Moskowitz
J Wisnivesky
机构：
[1] Mount Sinai School of Medicine,Division of General Internal Medicine
[2] University of Washington School of Medicine,Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine
[3] Yale School of Public Health and Yale School of Medicine,Department of Pathology
[4] Memorial Sloan-Kettering Hospital,Department of Health Evidence and Policy
[5] Mount Sinai School of Medicine,undefined
来源：
British Journal of Cancer | 2013年 / 109卷
关键词：
non-small cell lung cancer; lung cancer epidemiology; HIV; lung cancer prognosis; immunosuppression; competing risks;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1974 / 1980
页数：6
相关论文
共 50 条
  • [21] Perceptions of prognosis, treatment, and treatment impact on prognosis in non-small cell lung cancer
    Perez, EA
    CHEST, 1998, 114 (02) : 593 - 604
  • [22] Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients
    Lu, Baohua
    Zhang, Hongmei
    Zhang, Tongmei
    Cai, Yiran
    Hu, Ying
    Zheng, Hua
    Li, Baolan
    THORACIC CANCER, 2016, 7 (04) : 486 - 494
  • [23] Prognosis of patients with resected non-small cell lung cancer: Impact of clinical and pathologic variables
    Ravdin, PM
    Davis, G
    LUNG CANCER, 2006, 52 (02) : 207 - 212
  • [24] The prognosis of patients with non-small cell lung cancer found to have carcinomatous pleuritis at thoracotomy
    Ichinose, Y
    Tsuchiya, R
    Koike, T
    Kuwahara, O
    Nakagawa, K
    Yamato, Y
    Kobayashi, K
    Watanabe, Y
    Kase, M
    Yokoi, K
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 2000, 30 (12): : 1062 - 1066
  • [25] Prognosis of resected non-small cell lung cancer patients with carcinomatous pleuritis of minimal disease
    Ichinose, Y
    Tsuchiya, R
    Koike, T
    Kuwahara, O
    Nakagawa, K
    Yamato, Y
    Kobayashi, K
    Watanabe, Y
    Kase, M
    Yokoi, K
    LUNG CANCER, 2001, 32 (01) : 55 - 60
  • [26] Elevated expression of DTYMK is associated with poor prognosis in patients with Non-small cell lung cancer
    Wang, Wei
    Guo, Zhi-Hua
    Lu, Xin-Peng
    Liao, Dong-Jiang
    Peng, Gui-Lin
    Xu, Xin
    Yin, Wei-Qiang
    He, Jian-Xing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 22027 - 22033
  • [27] Xanthotoxol suppresses non-small cell lung cancer progression and might improve patients' prognosis
    Lin, Xian
    Liu, Jingfeng
    Zou, Yujiao
    Tao, Cheng
    Chen, Jian
    PHYTOMEDICINE, 2022, 105
  • [28] Radiotherapy for oligometastatic tumor improved the prognosis of patients with non-small cell lung cancer (NSCLC)
    Gong, Hong-yun
    Wang, Yi
    Han, Guang
    Song, Qi-bin
    THORACIC CANCER, 2019, 10 (05) : 1136 - 1140
  • [29] The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer
    Tian, Wen-Juan
    Liu, Shan-Shan
    Li, Bu-Rong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [30] Mutation of the TERT promoter leads to poor prognosis of patients with non-small cell lung cancer
    Jung, Soo-Jung
    Kim, Dong-Sun
    Park, Won-Jin
    Lee, Hyunsu
    Choi, In-Jang
    Park, Jae-Yong
    Lee, Jae-Ho
    ONCOLOGY LETTERS, 2017, 14 (02) : 1609 - 1614
12345